More info…
Catalyst Pharmaceutical Partners, Inc announced that the European Patent Office (EPO) granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent for the use of vigabatrin for the prevention of addiction to opioids (eg, oxycodone, hydrocodone) used in pain management.
